Teva Pharmaceuticals · 14 hours ago
Senior Director - Global SOX Leader
Parsippany, NJ
Full-time
Hybrid
Director/Executive
$240K/yr - $316K/yr
15+ years expTeva Pharmaceuticals is a leading manufacturer of generic medicines, committed to making good health more affordable and accessible. The Senior Director - Global SOX Leader will lead the SOX team, manage compliance aspects, and collaborate with various business functions to ensure the effectiveness of internal controls over financial reporting.
BiopharmaHealth CareMedicalPharmaceutical
Responsibilities
Lead and Mange the SOX and Finance Compliance global team, provide leadership, supervision and professionality
Lead SOX and GRC strategy. Consolidate deficiencies, evaluate magnitude, and report it to management. Monitor and promote remediation plan
Assist with key initiatives and projects such as risk & control assessment associated with changes in accounting systems (ERP), accounting rules, audit / SOX standards, and organizational structures
Develop and maintain positive work relationships with management with different organizational levels across various business functions' interview upper management
Collaborate with management to promote control consciousness and develop an effective & efficient internal control environment
Work in cooperation with Internal Audit, Global Compliance, Management and our External Auditors to ensure the adequacy of Teva’s ICFR. In addition, collaborate with IT Compliance Department in testing IT systems and access controls
Develop work plans for self-assessment of design and operating effectiveness of key SOX controls, perform and document process walkthroughs and detailed control testing to conclude on the effectiveness of SOX controls, and produce written reports and other documents with clearly organized thoughts
Mange team and provide leadership, supervisor and professionally
Other projects and duties as required/assigned
Qualification
Required
Bachelor's degree
Minimum 15 years of internal or external audit experience, comprising previous SOX experience in public accounting, consulting, or corporate internal audit
Previous audit experience with a major ERP system: i.e., SAP, Oracle
Big 4 public accounting experience
Previous audit experience and knowledge of SAP
Managerial experience
Professional certification i.e., CPA, CIA, or CISA
Strong understanding of internal control framework, business process analysis and risk assessment
Strong understanding of US GAAP
Strong MS Excel skills; proficient in all MS Office applications
Benefits
Comprehensive Health Insurance: Medical, Dental, Vision, and Prescription coverage starting on the first day of employment, providing the employee enrolls.
Retirement Savings: 401(k) with employer match, up to 6% and an annual 3.75% Defined Contribution to the 401k plan.
Time Off: Paid Time Off including vacation, sick/safe time, caretaker time and holidays.
Life and Disability Protection: Company paid Life and Disability insurance.
The total compensation package for this position may also include other elements, including a sign-on bonus, restricted stock units, and discretionary awards in addition to a full range of medical, financial, and/or other benefits (including 401(k) eligibility and various paid time off benefits, such as vacation, sick time, and parental leave), dependent on the position offered.
Company
Teva Pharmaceuticals
Teva Pharmaceuticals is a pharmaceutical company that develops generic and innovative medicines.
10001+ employees
H1B Sponsorship
Teva Pharmaceuticals has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (7)
2024 (4)
2023 (23)
2022 (48)
2021 (31)
2020 (33)
Funding
Current Stage
Public CompanyTotal Funding
$5.51BKey Investors
Royalty PharmaBerkshire Hathaway
2026-01-11Post Ipo Equity· $500M
2025-05-20Post Ipo Debt· $2.3B
2023-11-13Post Ipo Equity· $100M
Leadership Team
Dipankar Bhattacharjee
President & CEO: Generics Europe
Richard Francis
President and Chief Executive Officer
Recent News
2026-01-17
2026-01-14
2026-01-14
Company data provided by crunchbase